Summary

The North American Electrocardiograph (ECG) market is rising as the prevalence of cardiovascular disease rises, the older population grows, and improved and low-cost remote monitoring technologies become available. The market is predicted to develop due to many factors, including continuing advancements in ECG device technology, favourable government regulations, increased healthcare spending, a growth in the number of local government awareness campaigns, and the introduction of remote monitoring devices. Furthermore, increased healthcare expenditures and disposable income are driving market expansion. Furthermore, as urbanisation and industry expand, respiratory problems become more common, boosting the demand for ECG goods. North America, particularly the United States, is known around the world for pioneering advances in healthcare technology. The region has been at the forefront of creating and implementing cutting-edge medical gadgets, such as ECG machines, and has frequently established trends for the global industry. The region adheres to strong medical device regulatory standards, ensuring the safety, efficacy, and quality of ECG equipment. Adherence to these criteria creates confidence among healthcare providers and patients, contributing to ECG technology's widespread acceptance. Cardiovascular illnesses are relatively common in North America. As a result, precise diagnostic tools such as ECGs are in high demand for early detection, continuous monitoring, and successful therapy of cardiac diseases. North America's demographics are shifting towards an ageing population. With ageing comes an increased risk of cardiac disorders, fueling the demand for ECG equipment in healthcare settings for routine screenings and monitoring. The region has a well-developed healthcare infrastructure and easy access to cutting-edge medical facilities. ECG technology is widely available in hospitals, clinics, and specialised cardiac centres, ensuring its availability and utilisation in a variety of healthcare settings. North America promotes strong research collaborations among universities, medical institutions, and business companies, which drives ECG technology advancement. Collaboration results in breakthroughs such as AI-driven ECG analysis, portable monitoring systems, and personalised diagnoses.

According to the research report, “North America Electrocardiograph (ECG) Market Outlook, 2028” published by Bonafide Research, the North America market is anticipated to cross around USD 4 Billion market size by 2028. North America is demonstrating a trend of combining ECG technology with additional diagnostic modalities, such as imaging (echocardiography, MRI, and CT scans) and electrophysiology tests, for full cardiac evaluations. This integration provides a more complete picture of cardiac health. The region nurtures a thriving entrepreneurial ecosystem, particularly in healthcare technology. Start-ups focused on creating revolutionary ECG equipment, wearable technology, and software applications to improve cardiac diagnostics contribute to market dynamism. North America is at the forefront of the precision medicine movement, which aims to customise medical treatment to individual traits. ECG devices are increasingly being used in this manner, providing personalised diagnosis and treatment regimens based on particular patient profiles. Academic institutions and healthcare facilities around the region do considerable research and clinical studies to develop ECG technology. These activities result in the creation of novel features, algorithms, and applications for ECG devices, which contribute to market evolution. Wearable ECG devices have grown in popularity among North American customers. These devices provide continuous monitoring and real-time data collection, making them appealing to people who want to check their heart health as part of a proactive lifestyle. Healthcare legislation and insurance reimbursement processes in the region frequently encourage the adoption of modern medical technologies, such as ECGs. Reimbursement policies that are favourable encourage healthcare providers to invest in and use ECG devices for patient treatment. Efforts to standardise ECG data formats and improve interoperability across different ECG devices and healthcare systems are ongoing. Initiatives to standardise aim to streamline data exchange, improve compatibility, and ensure seamless integration within healthcare networks.

Based on report market is categorised into three major countries United States, Canada and Mexico. United States accounts for the largest market for Electrocardiograph (ECG) in North America.

The market for electrocardiographs (ECGs) in the United States has grown significantly in recent years, owing to an increase in the prevalence of cardiovascular illnesses and technical advancements in healthcare. ECG devices, being one of the most significant diagnostic tools in cardiology, play an important role in the early detection, monitoring, and treatment of a wide range of cardiac disorders. The United States leads the way in technical innovation in the healthcare business, moving the ECG market ahead. Because of the country's outstanding infrastructure and large R&D investments, the release of cutting-edge ECG equipment with enhanced capabilities has been accelerated. Furthermore, the rising prevalence of cardiovascular illnesses such as arrhythmias, coronary artery disease, and heart attacks has raised demand for ECG equipment in a range of healthcare settings. Reimbursement restrictions and healthcare changes in the United States have a considerable impact on the adoption and usage of ECG technologies. Healthcare facilities' decisions to integrate complex ECG technology are influenced by the reimbursement structure, which influences market dynamics. The country boasts a robust healthcare infrastructure that includes hospitals, clinics, research institutions, and healthcare providers that are supplied with cutting-edge medical technology. The availability of current infrastructure facilitates the incorporation and use of high-end ECG devices across a variety of healthcare settings, ensuring wider access to quality cardiac care. Electrocardiograms, or EKGs, are a common and useful diagnostic method used to assess heart health.

Based on product segment market is divided into resting electrocardiograph (ECG), stress electrocardiograph (ECG), holter monitors, event recorders and others. Resting electrocardiograph (ECG) product is expected to lead the North America Electrocardiograph (ECG) market.

The resting electrocardiograph (ECG) product is likely to emerge as the market leader in the North American electrocardiograph (ECG) market. For starters, the Resting ECG product captures the electrical activity of the heart during periods of rest with remarkable precision and reliability, giving clinicians a thorough baseline assessment of cardiac health. This diagnostic tool has proven invaluable in detecting a wide spectrum of cardiovascular problems, from arrhythmias to ischemic heart disease, allowing for timely intervention and management. Furthermore, the Resting ECG product distinguishes itself with its user-friendly design and straightforward interface, making it accessible to healthcare professionals from a variety of disciplines. The seamless integration of modern technology elements such as digital signal processing and real-time data transmission capabilities enhances its efficiency and elevates the standard of patient care. This product's compatibility with electronic health record (EHR) systems ensures seamless data management and facilitates collaborative decision-making among healthcare providers. Moreover, the Resting ECG product distinguishes itself through its ability to meet stringent quality standards and regulatory requirements, instilling confidence in both healthcare practitioners and regulatory bodies. The emphasis on data security and patient privacy also positions it as a trusted and compliant solution in the evolving landscape of healthcare technology.

In terms of end user segment market is majorly segmented into hospitals & clinics, home settings & ambulatory surgical centers (ASCs) and others. Among them Hospitals & clinics are major end users of electrocardiograph (ECG) product in North America.

Hospitals and clinics are the first points of contact for people seeking medical care, and cardiovascular disorders account for a sizable share of the overall health burden in North America. ECGs are important diagnostic tools for monitoring cardiac health because they allow healthcare providers to diagnose and monitor a variety of heart diseases, such as arrhythmias, myocardial infarctions, and other irregularities. The region's high prevalence of cardiovascular disorders emphasizes the significance of routine cardiac evaluations, making ECGs a standard and necessary component of diagnostic protocols in hospitals and clinics. Because ECG testing is non-invasive, it is an accessible and broadly applicable technique for people of all ages and health conditions. In addition, the integrated nature of healthcare systems in hospitals and clinics promotes the seamless incorporation of ECG data into electronic health records (EHRs). This facilitates continuity of care, allowing multiple healthcare providers to access and interpret ECG results, contributing to a collaborative approach to patient management.

Companies Covered in this report:

Koninklijke Philips N.V., GE HealthCare Technologies, Inc., Midmark Corporation, Schiller AG, Nihon Kohden Corporation, Baxter International Inc., Medline Industries, EDAN Instruments, Inc., Bionet Co., Ltd., Fukuda Denshi Co Ltd, OSI Systems, Inc., Mindray Medical International Limited.

Considered in this report:

• Geography: North America
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:

• North America Electrocardiograph (ECG) market Outlook with its value and forecast along with its segments
• Country-wise Electrocardiograph (ECG) market analysis
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Country covered in the report:

• United States
• Canada
• Mexico

By Product:

• Resting Electrocardiograph (ECG)
• Stress Electrocardiograph (ECG)
• Holter Monitors
• Event Recorders
• Others

By End User:

• Hospitals & Clinics
• Home Settings & Ambulatory Surgical Centers (ASCs)
• Others

The approach of the report:

This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources.

Intended audience:

This report can be useful to industry consultants, manufacturers, suppliers, associations, and organisations related to the Electrocardiograph (ECG) industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.






***Please Note: It will take 48 hours (2 Business days) for delivery of the report upon order confirmation.

ページTOPに戻る

Table of Contents